IRCT20200724048193N1已完成4 期
Comparing the Effect of Sevelamer Hydrochloride and Calcium Carbonate on Serum Level of hs-CRP, Soluable CD-14 and Endotoxin in Hemodialysis Patients
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with ESRD
- •Indication of treatment with phosphate binders
- •Hemodialysis preformation for more than three months
排除标准
- •Impossibility of alternative treatment with Sevelamer Hydrochloride or Calcium Carbonate
- •Cigarette, alcohol and drug abuse
- •History of immunological diseases
- •Any type of cancer
- •Recent active infection
- •Previous kidney transplant history
- •History of receiving immunosuppressive treatment
研究者
相似试验
已完成
3 期
Comparing the effect of sevelamer carbonate and sevelamer hydrochloride on blood level of phosphate, Ca, ph, bicarbonate and gastrointestinal complications in patients undergoing maintenance hemodialysisIRCT20141016019554N13Zanjan University of Medical Sciences44
招募中
2 期
Evaluation the effect of adding Sevelamer to the standard treatment of aluminum phosphide poisoning patientsIRCT20210720051946N7Shahid Beheshti University of Medical Sciences60
已完成
不适用
Evaluate the therapeutic effects of Sevelamer to reduce blood sugar levels, HbA1c, blood lipids and hs-CRP in patients with diabetic nephropathyDiabetic nephropathy.Diabetic nephropathyIRCT2016100423559N5Vice chancellor for research, Ardabil University of Medical Sciences30
已完成
3 期
Comparison of Sevelamer and Calcium carbonat on magnesium serum level in hemodialyzed patientsIRCT20180831040912N1Semnan University of Medical Sciences60
已完成
3 期
Powdered phosphate lowering medicine for Indian patients on hemodialysis.CTRI/2015/11/006342emcure pharmaceuticals50